Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS-COV-2.
Biomark Med
; 15(13): 1167-1175, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1379920
ABSTRACT
Aim:
To investigate whether C-reactive protein/albumin ratio (CAR) has an association with new onset atrial fibrillation (NOAF) in SARS-CoV-2. Materials &methods:
This study included 782 patients with SARS-CoV-2 infection, who were hospitalized in Turkey. The end point of the study was an occurrence of NOAF.Results:
NOAF was identified in 41 patients (5.2%). Subjects who developed NOAF had a higher CAR compared with those who did not develop NOAF (p < 0.001). In the multivariate logistic regression analysis the CAR (odds ratio = 2.879; 95% CI 1.063-7.793; p = 0.037) was an independent predictor of NOAF.Conclusion:
A high level of CAR in blood samples is associated with an increased risk of developing NOAF in SARS-CoV-2.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
C-Reactive Protein
/
Albumins
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
Biomark Med
Journal subject:
Biochemistry
/
Medicine
Year:
2021
Document Type:
Article
Affiliation country:
Bmm-2020-0866
Similar
MEDLINE
...
LILACS
LIS